Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrino-lytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Hirulog and Early Reperfusion or Occlusion (HERO) Study Group - White, HD (Lancet, 2001)